slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14.660 KRW | 0,00% | -1,87% | -6,39% |
Vakgebied
Aantal werknemers: 1 125
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Restrictions
95,0
%
| 452 801 | 94,6 % | 500 696 | 95,0 % | +10,58% |
Health Functional Food
5,0
%
| 25 864 | 5,4 % | 26 482 | 5,0 % | +2,39% |
Consolidated Adjustment
-0,1
%
| -1 067 | -0,2 % | -521 | -0,1 % | -51,16% |
Hearing Aid
0,1
%
| 1 286 | 0,3 % | 295 | 0,1 % | -77,04% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
98,0
%
| 467 170 | 97,6 % | 516 427 | 98,0 % | +10,54% |
Overseas
2,0
%
| 11 715 | 2,4 % | 10 526 | 2,0 % | -10,15% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Seung-Yul Baek
CEO | Chief Executive Officer | 65 | - |
Seung-Ho Baek
CEO | Chief Executive Officer | 68 | - |
Tae-Hong Choi
PSD | President | 67 | - |
Jonathan In Baek
BRD | Director/Board Member | 40 | 01-01-14 |
Se-Il Son
PRN | Corporate Officer/Principal | 55 | 01-01-13 |
Bong-Chul Cho
PRN | Corporate Officer/Principal | 60 | 01-01-13 |
Joo-Il Kim
PRN | Corporate Officer/Principal | 52 | 01-01-13 |
Han-Il Lim
PRN | Corporate Officer/Principal | 61 | 01-01-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Seung-Ho Baek
CEO | Chief Executive Officer | 68 | - |
Seung-Yul Baek
CEO | Chief Executive Officer | 65 | - |
Jonathan In Baek
BRD | Director/Board Member | 40 | 01-01-14 |
Yong-Won Bang
BRD | Director/Board Member | 65 | 24-03-20 |
Yeo-Won Son
BRD | Director/Board Member | 65 | - |
Yong-Ju Park
BRD | Director/Board Member | 70 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 22 190 194 | 12 879 824 ( 58,04 %) | 994 144 ( 4,480 %) | 58,04 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
994 144 | 4.48% | 10 760 724 $ |
Bedrijfsgegevens
Daewon Pharmaceutical Co., Ltd.
386 Cheonho-daero Seongdong-gu
04808, Seoul
+
http://www.daewonpharm.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,39% | 229 mln. | |
+38,59% | 727 mld. | |
-7,89% | 347 mld. | |
+15,66% | 319 mld. | |
+0,24% | 274 mld. | |
+13,21% | 238 mld. | |
+7,18% | 204 mld. | |
-6,26% | 203 mld. | |
+4,23% | 161 mld. | |
-1,70% | 160 mld. |
- Beurs
- Aandelen
- Koers A003220
- Onderneming Daewon Pharmaceutical Co., Ltd.